Skip to content
sellModerate cluster of 4

Todd S Thomson sold $150k of ACTU

director, other at ACTUATE THERAPEUTICS, INC.. 18,750 shares at an average of $8.00, traded Aug 14, 2024, filed Aug 16, 2024.

Warning score
41
Value
$150k
18,750 shares
Holdings after
1,184,795
-2% from before
From 52-week low
+6%
low $8.61, close $9.15
From 52-week high
0%
high $9.15, as of Aug 14, 2024

Score components

  • Role
    Director
    +15
  • Trade size
    $150k at market
    +11
  • Share of holdings sold
    Sold 1.6% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -7.9%, 3m -0.2%, 6m -10.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ACTUOct 12, 2026 · close 0.64
Since filing Aug 16, 2024: -92.6%SPY +44.0% · excess -136.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-24-090619, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 14, 2024CConversion
Common Stockindirect: By KVP II, L.P.
+1,058,318--1,105,636Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By KVOI, L.P.
+726,163--726,163Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By KVP II, L.P.
+69,445--1,175,081Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By KVOI, L.P.
+146,870--873,033Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By Kairos SPV Fund, LLC
+138,889--138,889Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By Kairos-Actuate SPV, L.P.
+230,597--230,597Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By Kairos SPV Fund, LLC
+132,908--271,797Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By Kairos-Actuate SPV, L.P.
+24,138--254,735Aug 16, 2024
Aug 14, 2024CConversion
Common Stockindirect: By Kairos SPV Fund, LLC
+49,984--321,781Aug 16, 2024
Aug 14, 2024XIn-the-money exercise
Common Stockindirect: By KVP II, L.P.
+28,464$5.27$150k1,203,545Aug 16, 2024
Aug 14, 2024SOpen-market sale
Common Stockindirect: By KVP II, L.P.
-18,750$8.00$150k1,184,795Aug 16, 2024
Aug 14, 2024CConversion
Series B-1 Redeemable Convertible Preferred Stockderivativeindirect: By KVP II, L.P.
+1,058,318--0Aug 16, 2024
Aug 14, 2024CConversion
Series B-2 Redeemable Convertible Preferred Stockderivativeindirect: By KVOI, L.P.
+726,163--0Aug 16, 2024
Aug 14, 2024CConversion
Series B-3 Redeemable Convertible Preferred Stockderivativeindirect: By KVP II, L.P.
+69,445--0Aug 16, 2024
Aug 14, 2024CConversion
Series B-3 Redeemable Convertible Preferred Stockderivativeindirect: By KVOI, L.P.
+146,870--0Aug 16, 2024
Aug 14, 2024CConversion
Series B-3 Redeemable Convertible Preferred Stockderivativeindirect: By Kairos SPV Fund, LLC
+138,889--0Aug 16, 2024
Aug 14, 2024CConversion
Series B-4 Redeemable Convertible Preferred Stockderivativeindirect: By Kairos-Actuate SPV, L.P.
+230,597--0Aug 16, 2024
Aug 14, 2024CConversion
Series B-4 Redeemable Convertible Preferred Stockderivativeindirect: By Kairos SPV Fund, LLC
+132,908--0Aug 16, 2024
Aug 14, 2024CConversion
Series C Redeemable Convertible Preferred Stockderivativeindirect: By Kairos-Actuate SPV, L.P.
+24,138--0Aug 16, 2024
Aug 14, 2024CConversion
Series C Redeemable Convertible Preferred Stockderivativeindirect: By Kairos SPV Fund, LLC
+49,984--0Aug 16, 2024
Aug 14, 2024XIn-the-money exercise
Warrant (Right to Buy)derivativeindirect: By KVP II, L.P.
+28,464--0Aug 16, 2024
Aug 12, 2024AGrant or award
Non-Qualified Stock Optionsderivative
+15,000$0.00$015,000Aug 16, 2024

Related signals

Other insiders at ACTUATE THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
45Moderate
ACTUsell
ACTUATE THERAPEUTICS, INC.
Todd S Thomson
director, owner
$1.6M
280,000 shares
-24%
58Moderate
ACTUbuy 3
ACTUATE THERAPEUTICS, INC.
Aaron G.L. Fletcher
director, owner
$500k
71,428 shares
+57%
58Moderate
ACTUbuy 3
ACTUATE THERAPEUTICS, INC.
Leslie W. Kreis
director, owner
$500k
71,428 shares
+57%
58Moderate
ACTUbuy 3
ACTUATE THERAPEUTICS, INC.
Bios Equity COF, LP
director, owner
$500k
71,428 shares
+57%
42Moderate
ACTUsell 4
ACTUATE THERAPEUTICS, INC.
Cavu Advisors, LLC
director, owner
$200k
24,999 shares
-8%
42Moderate
ACTUsell 4
ACTUATE THERAPEUTICS, INC.
Aaron G.L. Fletcher
director, owner
$200k
24,999 shares
-8%
42Moderate
ACTUsell 4
ACTUATE THERAPEUTICS, INC.
Bios Equity COF, LP
director, owner
$200k
24,999 shares
-8%
75Notable
ACTUbuy 3
ACTUATE THERAPEUTICS, INC.
Cavu Advisors, LLC
director, owner
$4.0M
500,000 shares
+57%
42Moderate
ACTUsell 4
ACTUATE THERAPEUTICS, INC.
Cavu Advisors, LLC
director, owner
$225k
24,999 shares
-8%
75Notable
ACTUbuy 3
ACTUATE THERAPEUTICS, INC.
Aaron G.L. Fletcher
director, owner
$4.0M
500,000 shares
+57%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Todd S Thomson sold $150k of ACTU | InsiderTell